Cameco Corporation produces and sells uranium. The company is headquartered in Saskatoon, Canada.
| Revenue (TTM) | $3.47B |
| Gross Profit (TTM) | $1.22B |
| EBITDA | $798.45M |
| Operating Margin | 9.11% |
| Return on Equity | 5.11% |
| Return on Assets | 2.98% |
| Revenue/Share (TTM) | $7.98 |
| Book Value | $11.81 |
| Price-to-Book | 8.32 |
| Price-to-Sales (TTM) | 12.36 |
| EV/Revenue | 16.96 |
| EV/EBITDA | 69.45 |
| Quarterly Earnings Growth (YoY) | -92.10% |
| Quarterly Revenue Growth (YoY) | -7.20% |
| Shares Outstanding | $435.53M |
| Float | $434.48M |
| % Insiders | 0.14% |
| % Institutions | 70.35% |
Volatility is currently contracting
Cameco's Q2 results weaken as lower uranium sales and Westinghouse earnings weigh on growth, but firm uranium prices support its longer-term outlook.
Constellation has several long-term service agreements to provide nuclear power to hyperscalers. Cameco Corporation benefits from the U.S. ban on Russian uranium.
The Department of Energy (DOE) has narrowed the competition for its proposed Nuclear Lifecycle Innovation Campuses (NLICs) to five states: Utah, Tennessee, Oklahoma, Louisiana, and Idaho. The selection advances an effort that could create new investment and contracting opportunities across nearly every part of the nuclear value chain.
Artificial intelligence has an electricity problem, and nuclear is the answer investors keep circling back to.
CCJ shares jump 7% despite a Q2 earnings miss, as investors weighed Westinghouse IPO plans, resilient guidance and a stretched valuation.
Cameco keeps 2026 uranium output intact, protects contract value and ties Westinghouse's 91-reactor AP1000 pipeline to durable fuel-cycle demand.
Project Prometheus has been announced by the U.S. Department of Energy (DOE). The project is a three-year, $60 million nuclear energy-focused initiative led by Idaho National Laboratory (INL).
Cameco NYSE: CCJ said its 2026 annual plan remains intact as it navigates temporary operational disruptions at its Saskatchewan uranium assets and sees strengthening conditions in long-term uranium contracting and nuclear-power development.
Cameco (CCJ) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.51 per share a year ago.
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco reports Q2 results: performance on track; production outlook unchanged; support for nuclear energy reinforces stronger long-term uranium prices.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CCJ and any ticker you trade — then tracks every position and per-strategy win rate.
